Suchergebnisse - "Caminati, Marco"

PubPharm (18)

1

Safety of Biological Therapies for Severe Asthma : An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2024

von Cutroneo, P. | Arzenton, E. | Furci, F. | +7

2

Is mild asthma truly mild? The patients' real-life setting

enthalten in: Expert review of respiratory medicine | 2022

von Guarnieri, G. | Batani, V. | Senna, G. | +3

3

Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase

enthalten in: The journal of allergy and clinical immunology. In practice | 2021

von Caminati, M. | Crisafulli, E. | Lunardi, C. | +6

CommentIn: J Allergy Clin Immunol Pract. 2021 Jul;9(7):2942-2943. - PMID 34246444

4

Biologics for the Treatments of Allergic Conditions : Severe Asthma

enthalten in: Immunology and allergy clinics of North America | 2020

von Caminati, M. | Bagnasco, D. | Rosenwasser, L. | +2

5

Minimal clinically important difference for asthma endpoints : an expert consensus report

enthalten in: European respiratory review : an official journal of the European Respiratory Society | 2020

von Bonini, M. | Di Paolo, M. | Bagnasco, D. | +14

6

The importance of being not significant : Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real life

enthalten in: Allergy | 2020

von Bagnasco, D. | Massolo, A. | Bonavia, M. | +18

7

Biologicals for severe asthma : what we can learn from real-life experiences?

enthalten in: Current opinion in allergy and clinical immunology | 2020

von Bagnasco, D. | Caminati, M. | Passalacqua, G.

8

Mepolizumab for severe eosinophilic asthma : a real-world snapshot on clinical markers and timing of response

enthalten in: Expert review of respiratory medicine | 2019

von Caminati, M. | Cegolon, L. | Vianello, A. | +7

9

What have recent advances in therapy taught us about severe asthma disease mechanisms?

enthalten in: Expert review of clinical immunology | 2019

von Caminati, M. | Polk, B. | Rosenwasser, L.

10

One year of mepolizumab. Efficacy and safety in real-life in Italy

enthalten in: Pulmonary pharmacology & therapeutics | 2019

von Bagnasco, D. | Caminati, M. | Menzella, F. | +15